Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: An association with malignancy

Rheumatology

Volumn 46, Issue 1, 2007, Pages 25-28

  Kaji, K ^e   Fujimoto, M ^e   Hasegawa, M ^e   Kondo, M ^e   Saito, Y ^e   Komura, K ^e   Matsushita, T ^e   Orito, H ^e   Hamaguchi, Y ^e   Yanaba, K ^a   Itoh, M ^a   Asano, Y ^b   Seishima, M ^c   Ogawa, F ^d   Sato, S ^d   Takehara, K ^e  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OGAKI MUNICIPAL HOSPITAL   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^e KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Dermatomyositis; Interstitial lung disease; Malignancy; Myositis specific autoantibodies

Indexed keywords

AUTOANTIBODY; CELL EXTRACT; NUCLEAR PROTEIN; PREDNISOLONE; SULFUR 35;

AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC VALUE; ERYTHEMA; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; INTERSTITIAL PNEUMONIA; ISOTOPE LABELING; JAPAN; LEUKEMIA CELL; LOW DRUG DOSE; MALE; MALIGNANT NEOPLASTIC DISEASE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RASH; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; DERMATOMYOSITIS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; IMMUNOPRECIPITATION; K562 CELLS; LUNG DISEASES, INTERSTITIAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEOPLASMS; NUCLEAR PROTEINS; PARANEOPLASTIC SYNDROMES; SCLERODERMA, SYSTEMIC;

EID: 33845596457     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel161     Document Type: Article

References (17)

1. Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993;100:116-23S.
2. Love LA, Leff RL, Fraser DD et al. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991;70:360-74.
3. Sato S, Hirakata M, Kuwana M et al. Autoantibodies to a 140 kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005;52:1571-6.
4. Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990;33:1361-70.
5. Ghirardello A, Zampieri S, Iaccarino L et al. Anti-Mi-2 antibodies. Autoimmunity 2005;38:79-83.
6. Komura K, Fujimoto M, Matsushita T et al. Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis. J Dermatol Sci 2005;40:215-17.
7. Howard OMZ, Dong HF, Yang D et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells. J Exp Med 2002;196:781-91.
8. Casciola-Rosen L, Nagaraju K, Plotz P et al. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 2005;201:591-601.
9. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
10. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
11. Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 1999;11:475-82.
12. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic, & Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
14. Targoff IN, Trieu EP et al. Autoantibodies to 155 kd and Se antigens in patients with clinically amyopathic dermatomyositis [abstract]. Arthritis Rheum 2000;43(Suppl 9):S194.
15. Hill CL, Zhang Y, Sigurgeirsson B et al. Frequency of specific cancer types in dermatomyositis and polymyositis: A population-based study. Lancet 2001;357:96-100.
16. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001;134:1087-95.
17. Chen YJ, Wu CY, Shen JL. Predicting factors of malignancy in dermatomyositis and polymyositis: A case-control study. Br J Dermatol 2001;144:825-31.